HCPCS Level IIdrugActive
J0689
Inj cefazolin sodium, baxter
BETOS: O1E
Effective: 2024-01-01
Referenced in 1 policies
Description
Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Cefazolin
Manufacturer
Baxter Healthcare Corporation
HCPCS Dosage
500 MG
Billing Units
6.0000
3
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.